Product NDC: | 63304-346 |
Proprietary Name: | ONDANSETRON |
Non Proprietary Name: | ONDANSETRON |
Active Ingredient(s): | 4 mg/1 & nbsp; ONDANSETRON |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63304-346 |
Labeler Name: | Ranbaxy Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078602 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120110 |
Package NDC: | 63304-346-05 |
Package Description: | 500 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (63304-346-05) |
NDC Code | 63304-346-05 |
Proprietary Name | ONDANSETRON |
Package Description | 500 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (63304-346-05) |
Product NDC | 63304-346 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ONDANSETRON |
Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
Route Name | ORAL |
Start Marketing Date | 20120110 |
Marketing Category Name | ANDA |
Labeler Name | Ranbaxy Pharmaceuticals Inc. |
Substance Name | ONDANSETRON |
Strength Number | 4 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |